Period Ending | Jan 28, 2012 | Jan 29, 2011 | Jan 31, 2010 |
---|
Total Revenue
|
10,364,000
|
9,613,000
|
8,632,000
| Cost of Revenue | 6,307,000 | 5,982,000 | 5,604,000 | |
Gross Profit
|
4,057,000
|
3,631,000
|
3,028,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 2,698,000 | 2,341,000 | 2,166,000 |
|
Non Recurring | 232,000 | 6,000 | 3,000 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
1,238,000
|
1,284,000
|
868,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 346,000 | 175,000 | 19,000 |
|
Earnings Before Interest And Taxes | 1,473,000 | 1,459,000 | 887,000 |
|
Interest Expense | 246,000 | 208,000 | 237,000 |
|
Income Before Tax | 1,227,000 | 1,251,000 | 650,000 |
|
Income Tax Expense | 377,000 | 446,000 | 202,000 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 850,000 | 805,000 | 457,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
850,000
|
805,000
|
448,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
850,000
|
805,000
|
448,000
|
|